It’s still up to the FDA to decide whether to greenlight the substances for compounding pharmacies to make—and pave the way for a peptide gold rush
Source link
About The Author
The Food and Drug Administration’s Pharmacy Compounding Advisory Committee voted in favor of several unapproved peptides up for compounding consideration.